With the new law on cannabis as a medicine, medicinal cannabis became marketable in Germany. Since then, it has been possible to bring it with you to other European countries. Read about what you need to consider here.
Tetrahydrocannabivarin (THCV) is one of the most medically important of the known cannabinoids. It is thought to act as an antagonist of the cannabinoid receptors at low doses, but surprisingly, it may act as an agonist at high doses, giving effects similar to THC. Since its discovery in 1973, THCV has gradually grown in importance within medical circles.
Medicinal cannabis is becoming more and more accepted the world over, as an increasing number of countries is moving towards a health-focused approach to the plant. Good news for patients, one would say. But the fight isn’t over yet, as shown in this report from Cannabis News Network.
Cannabidivarin (CBDV) is a naturally-occurring phytocannabinoid that occurs in small traces in certain strains of the cannabis plant. Although less studied than its more famous counterparts such as THC and CBD, research is beginning to uncover the medical potential of CBDV to treat epilepsy and other neurological conditions.
While just a few years ago, it was still taboo to talk about legalising cannabis in Morocco and Tunisia, nowadays, everyone is talking about it.
Cannabis advocacy continues to progress in 2017 with news that has given the cannabis community grounds for optimism. WHO will conduct its 1st official evaluation of cannabis' medicinal value. If the results are favourable, the stringent international restrictions on cannabis may ease and cannabis may finally be reclassified. Read more.
In February 2017, Ciudadanos and the OECM presented a Non-Legislative Motion in Congress in order to regulate medical cannabis in Spain. Its objective is to address the needs and demands of Spanish patients, as well as to open a parliamentary debate about therapeutic cannabis – a treatment backed by scientific evidence.
The political discussion around cannabis keeps returning to the results of studies. Now that the opponents of cannabis are faced with the positive experiences in many US states, Uruguay and Canada, their arguments are petering out, so instead, they have begun referring to what they claim is a lack of results from studies on cannabis. So far...
Opponents of cannabis like to call it a gateway drug. They say it is just one of many illegal substances, a launch pad toward a druggie lifestyle. Although this theory has long been disproved scientifically, this alternative fact is repeated endlessly like a mantra by opponents of legalisation. But what about withdrawal treatment? More on that.
On 20 February, the South African media reported that the country's government will soon be issuing the first licences permitting the production of medicinal cannabis in South Africa.
In 2009, TV host and rally navigator Bart Hissink was in an accident. His vehicle crashed against a tree at a speed of 160km/h, resulting in his being in a coma for two weeks.
For certain conditions, cannabis and cannabis-based medicines may be safer and more effective than current standard treatments. Medicinal cannabis patients in the US and elsewhere are beginning to replace or supplement conventional pharmaceuticals with cannabis, with very promising initial results.
You may be aware of some of the applications of cannabis and cannabinoids in treating a long list of diseases. Today we focus on its therapeutic potential to prevent and treat bone injuries or diseases, an area of medical application where research conducted over the last few years has yielded very promising results.
One of the hardest working people on the UK, if not European, cannabis scene, Clark French made time to talk with us on a recent visit to Amsterdam. In this, the first part of our interview, he discusses his personal experiences with cannabis and the difference in quality of life that it makes to him and to others.
There are thousands of disorders out there that have remained understudied due to their rarity and complexity. Cannabis and cannabinoid compounds may provide complex solutions to these complex diseases. Medicinal cannabis programs are now helping to discover these solutions and deliver them to the patients that desperately need them.
In this second instalment of its Irish miniseries, Cannabis News Network interviews Tom Curran. His wife, Marie Fleming, passed away 3 years ago. She suffered from Multiple Sclerosis (MS), which ended up taking her life. After Marie died, Tom came forward advocating for medicinal cannabis. Watch this interview with him here.
All over the world, there are countless people and organisations that lend their support to the cause of cannabis, and which are concerned by the fact that it is still not available to everyone in a way that is equitable and fair. The Daya Foundation researches and promotes alternative therapies, including the consumption of medicinal cannabis to relieve human suffering.
Cannabichromene (CBC) is an abundant naturally-occurring phytocannabinoid, and is thought to be the second most abundant cannabinoid in cannabis. CBC has been shown to produce antinociceptive (painkilling) and anti-inflammatory effects in rodents, and interest is now growing in its potential to treat gastrointestinal and inflammatory disorders in humans.
For a number of years now, German cannabis patients have been allowed to purchase cannabis flowers from the Netherlands via German pharmacies using a special permit. From the end of August, they will also be able to buy four strains from Canada.